Development of a novel chemoenzymatic route to enantiomerically enriched β-adrenolytic agents. A case study toward propranolol, alprenolol, pindolol, carazolol, moprolol, and metoprololPaweł Borowiecki & Beata Zdun & Natalia Popow & Magdalena Wiklińska & Tamara Reiter & Wolfgang KroutilPDF935 KBEN